These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1657077)

  • 21. In vivo and in vitro pharmacological studies of aminoglutethimide as an aromatase inhibitor.
    Santen RJ; Santner SJ; Tilsen-Mallett N; Rosen HR; Samojlik E; Veldhuis JD
    Cancer Res; 1982 Aug; 42(8 Suppl):3353s-3359s. PubMed ID: 7083200
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of aminoglutethimide on adrenal steroid secretion.
    Vermeulen A; Paridaens R; Heuson JC
    Clin Endocrinol (Oxf); 1983 Dec; 19(6):673-82. PubMed ID: 6652931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adrenal suppression with aminoglutethimide. III. Comparison of plasma delta 4- and delta 5-steroids in postmenopausal women treated for breast carcinoma.
    Samojlik E; Santen RJ
    J Clin Endocrinol Metab; 1978 Oct; 47(4):717-24. PubMed ID: 162517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adrenal suppression with aminoglutethimide. II. Differential effects of aminoglutethimide on plasma androstenedione and estrogen levels.
    Samojlik E; Santen RJ; Wells SA
    J Clin Endocrinol Metab; 1977 Sep; 45(3):480-7. PubMed ID: 903399
    [No Abstract]   [Full Text] [Related]  

  • 25. Preliminary study of hormone determinations during aminoglutethimide therapy for advanced breast cancer.
    Scaglia HE; Koliren L; Loruso A; Zylbersztein C; Ramos G; Díaz L; Soto E
    Eur J Gynaecol Oncol; 1984; 5(3):170-9. PubMed ID: 6234171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Second line endocrine treatment of postmenopausal advanced breast cancer. Preliminary endocrine results of a 5-arm randomized phase II trial of medium vs low dose aminoglutethimide, with or without hydrocortisone vs hydrocortisone alone (EORTC 10861).
    Bruning PF; Bonfrèr JM; Wildiers J; Jassem J; Beex LV; Schornagel J; Nooijen WJ
    J Steroid Biochem Mol Biol; 1990 Dec; 37(6):1013-9. PubMed ID: 2149501
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endocrine changes associated with relapse in advanced breast cancer patients on aminoglutethimide therapy.
    Dowsett M; Harris AL; Smith IE; Jeffcoate SL
    J Clin Endocrinol Metab; 1984 Jan; 58(1):99-104. PubMed ID: 6227629
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase II study of low dose aminoglutethimide 250 mg/day plus hydrocortisone in advanced postmenopausal breast cancer.
    Harris AL; Cantwell BM; Carmichael J; Dawes P; Robinson A; Farndon J; Wilson R
    Eur J Cancer Clin Oncol; 1989 Jul; 25(7):1105-11. PubMed ID: 2759165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of aromatase as treatment of breast carcinoma in postmenopausal women.
    Santen RJ; Boucher AE; Santner SJ; Henderson IC; Harvey H; Lipton A
    J Lab Clin Med; 1987 Mar; 109(3):278-89. PubMed ID: 3546561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low-dose aminoglutethimide therapy without glucocorticoid administration. Clinical and hormonal findings.
    Kahán Z; Tóth I; Vecsernyés M
    Oncology; 1992; 49(1):31-4. PubMed ID: 1542490
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low dose aminoglutethimide (125 mg twice daily) with hydrocortisone for the treatment of advanced postmenopausal breast cancer.
    Harris AL; Cantwell BM; Sainsbury JR; Needham G; Evans RG; Dawes PJ; Wilson R; Farndon J
    Breast Cancer Res Treat; 1986; 7 Suppl():S41-4. PubMed ID: 3742063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppression of estrogens with aminoglutethimide and hydrocortisone (medical adrenalectomy) as treatment of advanced breast carcinoma: a review.
    Santen RJ
    Breast Cancer Res Treat; 1981; 1(3):183-202. PubMed ID: 6293627
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum steroid hormone profiles in postmenopausal smokers and nonsmokers.
    Friedman AJ; Ravnikar VA; Barbieri RL
    Fertil Steril; 1987 Mar; 47(3):398-401. PubMed ID: 2951278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Steroid hormone profiles in women treated with aminoglutethimide for metastatic carcinoma of the breast.
    Samojlik E; Santen RJ; Kirschner MA; Ertel NH
    Cancer Res; 1982 Aug; 42(8 Suppl):3349s-3352s. PubMed ID: 7083199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanism of adrenal suppression by high-dose medroxyprogesterone acetate in breast cancer patients.
    van Veelen H; Willemse PH; Sleijfer DT; van der Ploeg E; Sluiter WJ; Doorenbos H
    Cancer Chemother Pharmacol; 1985; 15(2):167-70. PubMed ID: 3160504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alterations in the metabolism of oestrogens during treatment with aminoglutethimide in breast cancer patients. Preliminary findings.
    Lønning PE; Kvinnsland S; Thorsen T; Ueland PM
    Clin Pharmacokinet; 1987 Dec; 13(6):393-406. PubMed ID: 3436111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of exogenous estrogen on serum pregnenolone, cortisol, and androgens in postmenopausal women.
    Abraham GE; Maroulis GB
    Obstet Gynecol; 1975 Mar; 45(3):271-4. PubMed ID: 163457
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aromatase inhibitors for treatment of breast cancer: current concepts and new perspectives.
    Santen RJ
    Breast Cancer Res Treat; 1986; 7 Suppl():S23-35. PubMed ID: 3527304
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endocrine, pharmacokinetic and clinical studies of the aromatase inhibitor 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione ('pyridoglutethimide') in postmenopausal breast cancer patients.
    Dowsett M; MacNeill F; Mehta A; Newton C; Haynes B; Jones A; Jarman M; Lonning P; Powles TJ; Coombes RC
    Br J Cancer; 1991 Nov; 64(5):887-94. PubMed ID: 1931611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Aminoglutethimide and aminoglutethimide+tamoxifen treatment for advanced breast cancer].
    Hisamatsu K; Nomura Y; Tashiro H
    Gan To Kagaku Ryoho; 1992 Oct; 19(12):2017-23. PubMed ID: 1417009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.